Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos
Public Domain
-
2011/01/20
-
Details
-
Personal Author:
-
Description:We have recently shown that the dissolution of ZnO nanoparticles and Zn2þ shedding leads to a series of sublethal and lethal toxicological responses at the cellular level that can be alleviated by iron doping. Iron doping changes the particle matrix and slows the rate of particle dissolution. To determine whether iron doping of ZnO also leads to lesser toxic effects in vivo, toxicity studies were performed in rodent and zebrafish models. First, we synthesized a fresh batch of ZnO nanoparticles doped with 1-10 wt % of Fe. These particles were extensively characterized to confirm their doping status, reduced rate of dissolution in an exposure medium, and reduced toxicity in a cellular screen. Subsequent studies compared the effects of undoped to doped particles in the rat lung, mouse lung, and the zebrafish embryo. The zebrafish studies looked at embryo hatching and mortality rates as well as the generation of morphological defects, while the endpoints in the rodent lung included an assessment of inflammatory cell infiltrates, LDH release, and cytokine levels in the bronchoalveolar lavage fluid. Iron doping, similar to the effect of the metal chelator, DTPA, interfered in the inhibitory effects of Zn2þ on zebrafish hatching. In the oropharyngeal aspiration model in the mouse, iron doping was associated with decreased polymorphonuclear cell counts and IL-6 mRNA production. Doped particles also elicited decreased heme oxygenase 1 expression in the murine lung. In the intratracheal instillation studies in the rat, Fe doping was associated with decreased polymorphonuclear cell counts, LDH, and albumin levels. All considered, the above data show that Fe doping is a possible safe design strategy for preventing ZnO toxicity in animals and the environment. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1936-0851
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:5
-
Issue:2
-
NIOSHTIC Number:nn:20038504
-
Citation:ACS Nano 2011 Jan; 5(2):1223-1235
-
Contact Point Address:Andre E. Nel, Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, USA
-
Email:anel@mednet.ucla.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2011
-
Peer Reviewed:True
-
Source Full Name:ACS Nano
-
Collection(s):
-
Main Document Checksum:urn:sha-512:fe02381fcfeafc7a4b449438b634b975fec51170385aa24b33ccdab0f0b942ccb34db5d14e3b46df1cb520d776048a2e0aa974c6c47dbb56e3c08b4923ca18ea
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like